Dramatic Improvement of Fibromyalgia Symptoms After Treatment With Topiramate for Coexisting MigraineKARARIZOU, Evangelia; ANAGNOSTOU, Evangelos; TRIANTAFYLLOU, Nikolaos I et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 5, pp 721-723, issn 0271-0749, 3 p.Article

Association of Brain Serotonin Transporter Availability and Brain-Derived Neurotrophic Factor in Models of Serotonin Transporter Genotypes in Healthy SubjectsCHOU, Yuan-Hwa; CHEN, Chih-Ken; LIAO, Mei-Hsiu et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 3, pp 432-435, issn 0271-0749, 4 p.Article

Exogenous Delta⁹-Tetrahydrocannabinol Influences Circulating Endogenous Cannabinoids in HumansWALTER, Carmen; FERREIROS, Nerea; BISHAY, Philipp et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 5, pp 699-705, issn 0271-0749, 7 p.Article

Interaction Between Novelty Seeking and the Aldehyde Dehydrogenase 2 Gene in Heroin-Dependent PatientsLEE, Sheng-Yu; WANG, Tzu-Yun; YEN KUANG YANG et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 3, pp 386-390, issn 0271-0749, 5 p.Article

Risk for Adverse Events and Discontinuation Due To Adverse Events of Ziprasidone Monotherapy Relative to Placebo in the Acute Treatment of Bipolar Depression, Mania, and SchizophreniaKEMING GAO; PAPPADOPULOS, Elizabeth; KARAYAL, Onur N et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 3, pp 425-431, issn 0271-0749, 7 p.Article

Effectiveness and Tolerability of Duloxetine in 2 Different Ethnic Samples: A Prospective Observational Cohort StudyCOLLAZOS, Francisco; RAMOS, Mar; QURESHI, Adil et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 2, pp 254-256, issn 0271-0749, 3 p.Article

Examining Levels of Antipsychotic Adherence to Better Understand NonadherenceREMINGTON, Gary; TEO, Celine; MANN, Steve et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 2, pp 261-263, issn 0271-0749, 3 p.Article

An Open-Label, Randomized, Controlled Trial of Zotepine and Risperidone for Acutely III, Hospitalized, Schizophrenic Patients With Symptoms of AgitationCHAN, Hung-Yu; LIN, An-Sheng; CHEN, Kun-Po et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 6, pp 747-752, issn 0271-0749, 6 p.Article

Population Pharmacokinetic-Pharmacodynamic Modeling of Haloperidol in Patients With Schizophrenia Using Positive and Negative Syndrome Rating ScaleVENKATESH PILLA REDDY; KOZIELSKA, Magdalena; PROOST, Johannes H et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 6, pp 731-739, issn 0271-0749, 9 p.Article

A Comparison of Duloxetine Plasma Levels in Postbariatric Surgery Patients Versus Matched Nonsurgical Control SubjectsROERIG, James L; STEFFEN, Kristine J; ZIMMERMAN, Cheryl et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 4, pp 479-484, issn 0271-0749, 6 p.Article

Adverse Events in Elderly Users of Antipsychotic Pharmacotherapy in the Province of Manitoba: A Retrospective Cohort StudyVASILYEVA, Irina; BISCONTRI, Robert G; ENNS, Murray W et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 1, pp 24-30, issn 0271-0749, 7 p.Article

Association of a Functional Polymorphism in Neuropeptide Y With Antipsychotic-Induced Weight Gain in Schizophrenia PatientsTIWARI, Arun K; BRANDL, Eva J; WEBER, Caroline et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 1, pp 11-17, issn 0271-0749, 7 p.Article

Atomoxetine Treatment of Attention-Deficit/Hyperactivity Disorder in Young Adults With Assessment of Functional Outcomes: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialDURELL, Todd M; ADLER, Lenard A; WILLIAMS, Dave W et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 1, pp 45-54, issn 0271-0749, 10 p.Article

Atypical Antipsychotic Drugs and Pregnancy Outcome: A Prospective; Cohort StudyHABERMANN, Frank; FRITZSCHE, Juliane; FUHLBRÜCK, Frederike et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 4, pp 453-462, issn 0271-0749, 10 p.Article

CNR1 Gene and Risk of the Metabolic Syndrome in Patients With SchizophreniaWEIPING YU; DE HERT, Marc; MOONS, Tim et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 2, pp 186-192, issn 0271-0749, 7 p.Article

Comparison of Treatment Response in Second-Episode Versus First-Episode SchizophreniaEMSLEY, Robin; OOSTHUIZEN, Petrus; KOEN, Liezl et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 1, pp 80-83, issn 0271-0749, 4 p.Article

Concentration of Donepezil to the Cognitive Response in Alzheimer DiseaseYANG, Yuan-Han; CHEN, Chun-Hung; CHOU, Mei-Chuan et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 3, pp 351-355, issn 0271-0749, 5 p.Article

Effects of Controlled Discontinuation of Long-Term Used Antipsychotics on Weight and Metabolic Parameters in Individuals With Intellectual DisabilityDE KUIJPER, Gerda; MULDER, Hans; EVENHUIS, Heleen et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 4, pp 520-524, issn 0271-0749, 5 p.Article

Effects of Theobromine and Caffeine on Mood and VigilanceJUDELSON, Daniel A; PRESTON, Amy G; MILLER, Debra L et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 4, pp 499-506, issn 0271-0749, 8 p.Article

Estimating Dopamine D₂ Receptor Occupancy for Doses of 8 Antipsychotics: A Meta-AnalysisLAKO, Irene M; VAN DEN HEUVEL, Edwin R; KNEGTERING, Henrikus et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 5, pp 675-681, issn 0271-0749, 7 p.Article

Insight and Hostility as Predictors and Correlates of Nonadherence in the European First Episode Schizophrenia TrialCZOBOR, Pál; VOLAVKA, Jan; DERKS, Eske M et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 2, pp 258-261, issn 0271-0749, 4 p.Article

N-Acetylcysteine Augmentation to Tranylcypromine in Treatment-Resistant Major DepressionCARVALHO, André F; MACEDO, Danielle S; GOULIA, Panagiota et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 5, pp 719-720, issn 0271-0749, 2 p.Article

Treatment of Clozapine-Induced Constipation With BethanecholPOETTER, Connie E; STEWART, Jonathan T.Journal of clinical psychopharmacology. 2013, Vol 33, Num 5, pp 713-714, issn 0271-0749, 2 p.Article

Growth Hormone Response to Catecholamine Depletion in Unmedicated, Remitted Subjects With Major Depressive Disorder and Healthy ControlsHOMAN, Philipp; DREVETS, Wayne C; HASLER, Gregor et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 5, pp 621-626, issn 0271-0749, 6 p.Article

High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms: The ZEBRAS StudyGOFF, Donald C; MCEVOY, Joseph P; CITROME, Leslie et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 4, pp 485-490, issn 0271-0749, 6 p.Article